Bristol Myers Squibb Stock Probability Of Bankruptcy

BMY Stock  USD 53.25  0.70  1.33%   
Bristol Myers' odds of distress is below 1% at this time. The company is very unlikely to encounter any financial hardship in the next two years. Chance Of Bankruptcy shows the probability of financial distress over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Bristol balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Bristol Myers Piotroski F Score and Bristol Myers Altman Z Score analysis.
  

Bristol Probability Of Bankruptcy Analysis

Bristol Myers' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total45.6B40.7B41.5B43.5B
Total Assets109.3B96.8B95.2B99.9B

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Bristol Myers Probability Of Bankruptcy

    
  Less than 1%  
Most of Bristol Myers' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bristol Myers Squibb is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Bristol Myers probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Bristol Myers odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Bristol Myers Squibb financial health.
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.09)
Dividend Share
2.31
Earnings Share
3.86
Revenue Per Share
21.753
Quarterly Revenue Growth
0.006
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bristol Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Bristol Myers is extremely important. It helps to project a fair market value of Bristol Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Bristol Myers' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bristol Myers' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bristol Myers' interrelated accounts and indicators.
0.810.890.98-0.070.760.97-0.160.880.990.940.850.960.60.120.880.860.670.98-0.880.830.68-0.970.370.970.930.79-0.5-0.350.910.980.860.9
0.810.550.81-0.10.770.810.10.60.830.870.670.650.62-0.220.730.470.440.77-0.780.680.47-0.740.220.770.80.43-0.17-0.190.610.710.510.79
0.890.550.840.130.50.82-0.140.820.850.760.730.930.620.360.810.940.660.85-0.750.730.52-0.870.280.810.730.82-0.51-0.310.830.890.790.71
0.980.810.84-0.170.820.98-0.210.890.990.930.890.950.56-0.020.910.820.660.99-0.90.870.71-0.990.440.990.970.76-0.54-0.370.930.980.850.94
-0.07-0.10.13-0.17-0.11-0.030.35-0.45-0.11-0.05-0.16-0.130.440.49-0.150.1-0.06-0.17-0.06-0.07-0.590.19-0.45-0.23-0.26-0.070.43-0.13-0.21-0.19-0.16-0.21
0.760.770.50.82-0.110.88-0.290.580.80.860.870.620.53-0.150.810.470.370.8-0.890.840.52-0.750.540.820.90.33-0.35-0.510.730.750.630.9
0.970.810.820.98-0.030.88-0.190.810.980.950.90.90.630.030.90.790.60.97-0.940.880.63-0.950.410.970.970.7-0.47-0.420.90.950.820.94
-0.160.1-0.14-0.210.35-0.29-0.19-0.33-0.18-0.07-0.32-0.240.15-0.1-0.26-0.24-0.22-0.230.19-0.31-0.290.27-0.55-0.25-0.28-0.160.50.42-0.33-0.27-0.26-0.27
0.880.60.820.89-0.450.580.81-0.330.870.770.780.940.30.040.820.790.640.9-0.680.720.83-0.920.520.910.860.79-0.7-0.240.90.940.840.81
0.990.830.850.99-0.110.80.98-0.180.870.960.870.950.610.050.90.840.660.99-0.90.850.68-0.980.40.980.950.77-0.51-0.370.930.970.860.92
0.940.870.760.93-0.050.860.95-0.070.770.960.850.840.680.070.860.710.550.94-0.90.810.63-0.890.370.940.940.61-0.4-0.360.870.90.820.92
0.850.670.730.89-0.160.870.9-0.320.780.870.850.820.530.050.840.710.410.87-0.930.850.59-0.870.570.870.90.6-0.48-0.430.870.880.750.86
0.960.650.930.95-0.130.620.9-0.240.940.950.840.820.50.170.840.930.690.95-0.80.780.7-0.970.40.940.870.88-0.63-0.330.930.980.870.82
0.60.620.620.560.440.530.630.150.30.610.680.530.50.190.640.570.210.56-0.750.60.01-0.54-0.130.520.510.39-0.01-0.130.50.510.40.55
0.12-0.220.36-0.020.49-0.150.03-0.10.040.050.070.050.170.19-0.040.340.150.04-0.06-0.1-0.09-0.02-0.17-0.02-0.090.240.09-0.050.160.10.3-0.11
0.880.730.810.91-0.150.810.9-0.260.820.90.860.840.840.64-0.040.760.540.9-0.860.950.69-0.90.460.910.920.64-0.52-0.350.860.90.780.95
0.860.470.940.820.10.470.79-0.240.790.840.710.710.930.570.340.760.630.83-0.730.750.53-0.880.280.80.710.92-0.57-0.350.850.870.820.68
0.670.440.660.66-0.060.370.6-0.220.640.660.550.410.690.210.150.540.630.69-0.460.450.43-0.650.420.660.550.53-0.53-0.580.70.670.670.52
0.980.770.850.99-0.170.80.97-0.230.90.990.940.870.950.560.040.90.830.69-0.890.850.72-0.990.451.00.960.76-0.58-0.40.960.990.890.93
-0.88-0.78-0.75-0.9-0.06-0.89-0.940.19-0.68-0.9-0.9-0.93-0.8-0.75-0.06-0.86-0.73-0.46-0.89-0.86-0.420.87-0.36-0.87-0.89-0.590.350.42-0.85-0.85-0.71-0.87
0.830.680.730.87-0.070.840.88-0.310.720.850.810.850.780.6-0.10.950.750.450.85-0.860.62-0.860.540.860.890.64-0.55-0.470.80.840.720.93
0.680.470.520.71-0.590.520.63-0.290.830.680.630.590.70.01-0.090.690.530.430.72-0.420.62-0.720.530.770.770.61-0.59-0.110.710.760.780.76
-0.97-0.74-0.87-0.990.19-0.75-0.950.27-0.92-0.98-0.89-0.87-0.97-0.54-0.02-0.9-0.88-0.65-0.990.87-0.86-0.72-0.44-0.98-0.94-0.830.60.35-0.95-0.99-0.86-0.91
0.370.220.280.44-0.450.540.41-0.550.520.40.370.570.4-0.13-0.170.460.280.420.45-0.360.540.53-0.440.490.520.17-0.75-0.760.510.480.450.51
0.970.770.810.99-0.230.820.97-0.250.910.980.940.870.940.52-0.020.910.80.661.0-0.870.860.77-0.980.490.980.74-0.6-0.390.950.980.890.95
0.930.80.730.97-0.260.90.97-0.280.860.950.940.90.870.51-0.090.920.710.550.96-0.890.890.77-0.940.520.980.65-0.56-0.370.90.950.820.98
0.790.430.820.76-0.070.330.7-0.160.790.770.610.60.880.390.240.640.920.530.76-0.590.640.61-0.830.170.740.65-0.51-0.110.760.80.780.6
-0.5-0.17-0.51-0.540.43-0.35-0.470.5-0.7-0.51-0.4-0.48-0.63-0.010.09-0.52-0.57-0.53-0.580.35-0.55-0.590.6-0.75-0.6-0.56-0.510.55-0.65-0.63-0.6-0.52
-0.35-0.19-0.31-0.37-0.13-0.51-0.420.42-0.24-0.37-0.36-0.43-0.33-0.13-0.05-0.35-0.35-0.58-0.40.42-0.47-0.110.35-0.76-0.39-0.37-0.110.55-0.46-0.38-0.39-0.38
0.910.610.830.93-0.210.730.9-0.330.90.930.870.870.930.50.160.860.850.70.96-0.850.80.71-0.950.510.950.90.76-0.65-0.460.960.940.86
0.980.710.890.98-0.190.750.95-0.270.940.970.90.880.980.510.10.90.870.670.99-0.850.840.76-0.990.480.980.950.8-0.63-0.380.960.890.91
0.860.510.790.85-0.160.630.82-0.260.840.860.820.750.870.40.30.780.820.670.89-0.710.720.78-0.860.450.890.820.78-0.6-0.390.940.890.81
0.90.790.710.94-0.210.90.94-0.270.810.920.920.860.820.55-0.110.950.680.520.93-0.870.930.76-0.910.510.950.980.6-0.52-0.380.860.910.81
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Bristol Myers Squibb has a Probability Of Bankruptcy of 1.0%. This is 97.69% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 97.49% higher than that of the company.

Bristol Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bristol Myers' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bristol Myers could also be used in its relative valuation, which is a method of valuing Bristol Myers by comparing valuation metrics of similar companies.
Bristol Myers is currently under evaluation in probability of bankruptcy category among related companies.

Bristol Myers Main Bankruptcy Drivers

201920202021202220232024 (projected)
Return On Assets0.460.0265(0.0759)0.0640.06530.0843
Asset Turnover0.622.120.20.360.480.88
Net Debt35.2B37.1B31.6B31.6B30B31.5B
Total Current Liabilities18.3B19.1B21.9B21.9B22.3B23.4B
Non Current Liabilities Total59.9B61.5B51.4B43.8B43.4B45.6B
Total Assets129.9B118.5B109.3B96.8B95.2B99.9B
Total Current Assets29.4B30.2B33.3B27.3B31.8B33.4B
Total Cash From Operating Activities8.1B14.1B16.2B13.1B13.9B14.6B

Bristol Myers ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bristol Myers' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bristol Myers' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Bristol Fundamentals

About Bristol Myers Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bristol Myers Squibb's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bristol Myers using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bristol Myers Squibb based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company was founded in 1887 and is headquartered in New York, New York. Bristol-Myers Squibb operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 32200 people.

Bristol Myers Investors Sentiment

The influence of Bristol Myers' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bristol. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Bristol Myers' public news can be used to forecast risks associated with an investment in Bristol. The trend in average sentiment can be used to explain how an investor holding Bristol can time the market purely based on public headlines and social activities around Bristol Myers Squibb. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bristol Myers' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bristol Myers' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bristol Myers' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bristol Myers.

Bristol Myers Implied Volatility

    
  26.54  
Bristol Myers' implied volatility exposes the market's sentiment of Bristol Myers Squibb stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bristol Myers' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bristol Myers stock will not fluctuate a lot when Bristol Myers' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bristol Myers in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bristol Myers' short interest history, or implied volatility extrapolated from Bristol Myers options trading.

Pair Trading with Bristol Myers

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bristol Myers position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bristol Stock

  0.69MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr

Moving against Bristol Stock

  0.7MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
  0.6MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.56KA Kineta Inc Report 29th of March 2024 PairCorr
  0.56VBIV VBI Vaccines Financial Report 20th of May 2024 PairCorr
The ability to find closely correlated positions to Bristol Myers could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bristol Myers when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bristol Myers - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bristol Myers Squibb to buy it.
The correlation of Bristol Myers is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bristol Myers moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bristol-Myers Squibb moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bristol Myers can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bristol-Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:

Complementary Tools for Bristol Stock analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Transaction History
View history of all your transactions and understand their impact on performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.09)
Dividend Share
2.31
Earnings Share
3.86
Revenue Per Share
21.753
Quarterly Revenue Growth
0.006
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.